首站-论文投稿智能助手
典型文献
Impact of alpha-synuclein pathology on adult neurogenesis: evidence for multilayered mechanisms
文献摘要:
Parkinson's disease (PD) is the second most common neurodegenerative disease affecting 8–10 million people worldwide. Moreover, PD is the fastest-growing neurodegenerative disease and it is predicted that the number of patients will double in the next thirty years. Neuropathologically, PD is characterized by the presence of protein aggregations called Lewy bodies (LB) and by degeneration of dopaminergic neurons in the substantia nigra pars compacta, which give rise to classical motor symptoms. However, overwhelming scientific evidence shows that PD is a multilayered disease. LB pathology affects different brain regions and neuronal populations leading to various non-motor symptoms, such as cognitive, sleep, and sensory impairments, mood and metabolic disorders, etc., some of which, interestingly, appear long before the hallmark motor symptoms. A main component of LB is the protein alpha-synuclein (α-syn). Accumulation and aggregation of α-syn is a characteristic feature that can be observed in synucleinopathies, a group of diseases which PD, dementia with Lewy bodies (DLB), and multiple system atrophy belongs to. While DLB is characterized by progressive dementia, about 80% of PD patients experience some form of cognitive impairment. Therefore, PD and DLB together constitute the second leading cause of neurodegenerative dementias. Moreover, it is proposed that α-syn-associated pathology in cortical and hippocampal (Hipp) brain areas is causing cognitive deficits and dementia in PD and DLB. Alterations in adult neurogenesis may represent a potential pathomechanism.
文献关键词:
作者姓名:
Jana Bonsberger;Franziska Richter;Milos Stanojlovic
作者机构:
Department of Pharmacology,Toxicology and Pharmacy,University of Veterinary Medicine,Hannover,Germany
引用格式:
[1]Jana Bonsberger;Franziska Richter;Milos Stanojlovic-.Impact of alpha-synuclein pathology on adult neurogenesis: evidence for multilayered mechanisms)[J].中国神经再生研究(英文版),2022(07):1491-1492
A类:
Neuropathologically,dementias,Hipp,pathomechanism
B类:
Impact,alpha,pathology,adult,neurogenesis,evidence,multilayered,mechanisms,Parkinson,second,most,common,neurodegenerative,affecting,million,people,worldwide,Moreover,fastest,growing,predicted,that,number,patients,will,double,next,thirty,years,characterized,by,presence,protein,aggregations,called,Lewy,bodies,degeneration,dopaminergic,neurons,substantia,nigra,pars,compacta,which,give,rise,classical,motor,symptoms,However,overwhelming,scientific,shows,affects,different,brain,regions,neuronal,populations,leading,various,such,cognitive,sleep,sensory,impairments,mood,metabolic,disorders,etc,some,interestingly,appear,before,hallmark,main,component,Accumulation,characteristic,feature,can,observed,synucleinopathies,group,diseases,DLB,multiple,system,atrophy,belongs,While,progressive,about,experience,form,Therefore,together,constitute,cause,proposed,associated,cortical,hippocampal,areas,causing,deficits,Alterations,may,represent,potential
AB值:
0.551092
相似文献
Dementia in military and veteran populations: a review of risk factors—traumatic brain injury, post?traumatic stress disorder, deployment, and sleep
Zara Raza;Syeda F.Hussain;Suzanne Ftouni;Gershon Spitz;Nick Caplin;Russell G.Foster;Renata S.M.Gomes-Research and Innovation,Blind Veterans UK,12?14 Harcourt Street,London W1H 4HD,UK;BRAVO VICTOR,Research,12?14 Harcourt Street,London W1H 4HD,UK;Circadian Therapeutics,Oxford OX11BY,UK;School of Psychological Sciences,Monash University,18 Innovation Walk,Clayton Campus,Wellington Road,Melbourne,VIC 3800,Australia;Sleep&Circadian Neuroscience Institute (SCNi),Nuffield Department of Clinical Neurosciences,Sir William Dunn School of Pathology,Oxford Molecular Pathology Institute,University of Oxford,South Parks Road,Oxford OX13RF,UK;Northern Hub for Veterans and Military Families Research,Department of Nursing,Midwifery and Health,Faculty of Health and Life Sciences,Northumbria University,Newcastle NE77XA,UK
Targeted lipidomics reveals plasmalogen phosphatidylethanolamines and storage triacylglycerols as the major systemic lipid aberrations in Bietti crystalline corneoretinal dystrophy
Shijing Wu;Sin Man Lam;Huajin Li;Binhua Jiang;Zixi Sun;Tian Zhu;Xing Wei;Xuan Zou;Guanghou Shui;Ruifang Sui-Department of Ophthalmology,State Key Laboratory of Complex Severe and Rare Diseases,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100730,China;State Key Laboratory of Molecular Developmental Biology,Institute of Genetics and Developmental Biology,Chinese Academy of Sciences,Beijing 100101,China;Department of Ophthalmology,The First Affiliated Hospital of Fujian Medical University,Fuzhou,Fujian 350004,China;LipidALL Technologies Company Limited,Changzhou,Jiangsu 213022,China
CHCHD2 maintains mitochondrial contact site and cristae organizing system stability and protects against mitochondrial dysfunction in an experimental model of Parkinson’s disease
Lu Lin;Mao Hengxu;Zhou Miaomiao;Lin Yuwan;Dai Wei;Qiu Jiewen;Xiao Yousheng;Mo Mingshu;Zhu Xiaoqin;Wu Zhuohua;Pei Zhong;Guo Wenyuan;Xu Pingyi;Chen Xiang-Department of Neurology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510120, China;Department of Neurology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China;School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, Guangdong 511436, China;Department of Neurology, National Key Clinical Department and Key Discipline of Neurology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong 510080, China
Alzheimer's disease:current status and perspective
Wenying Liu;Serge Gauthier;Jianping Jia-Innovation Center for Neurological Disorders and Department of Neurology,Xuanwu Hospital,Capital Medical University,National Clinical Research Center for Geriatric Diseases,Beijing 100053,China;Departments of Neurology and Neurosurgery,and Department of Psychiatry,McGill Centre for Studies in Aging,McGill University,Montreal H4H1R3,Canada;Beijing Key Laboratory of Geriatric Cognitive Disorders,Beijing 100053,China;Clinical Center for Neurodegenerative Disease and Memory Impairment,Capital Medical University,Beijing 100053,China;Center of Alzheimer's Disease,Beijing Institute of Brain Disorders,Collaborative Innovation Center for Brain Disorders,Capital Medical University,Beijing 100053,China;Key Laboratory of Neurodegenerative Diseases,Ministry of Education,Beijing 100053,China
An App knock-in rat model for Alzheimer's disease exhibiting Aβ and tau pathologies,neuronal death and cognitive impairments
Keliang Pang;Richeng Jiang;Wei Zhang;Zhengyi Yang;Lin-Lin Li;Makoto Shimozawa;Simone Tambaro;Johanna Mayer;Baogui Zhang;Man Li;Jiesi Wang;Hang Liu;Ailing Yang;Xi Chen;Jiazheng Liu;Bengt Winblad;Hua Han;Tianzi Jiang;Weiwen Wang;Per Nilsson;Wei Guo;Bai Lu-School of Pharmaceutical Sciences,IDG/McGovern Institute for Brain Research,Tsinghua University-Peking University Joint Center for Life Sciences,Tsinghua University,Beijing,China;R&D Center for the Diagnosis and Treatment of Major Brain Diseases,Research Institute of Tsinghua University in Shenzhen,Shenzhen,Guangdong,China;Beijing Tiantan Hospital,Advanced Innovation Center for Human Brain Protection,Capital Medical University,Beijing,China;Department of Neurobiology,Care Sciences and Society,Division of Neurogeriatrics,Center for Alzheimer Research,Karolinska Institutet,Stockholm,Sweden;Department of Otorhinolaryngology Head and Neck Surgery,The First Hospital of Jilin University,Changchun,China;CAS Key Laboratory of Mental Health,Institute of Psychology,Chinese Academy of Sciences,and Department of Psychology,University of Chinese Academy of Sciences,Beijing,China;Brainnetome Center,Institute of Automation,Chinese Academy of Sciences,Beijing,China;Research Center for Brain-inspired Intelligence,National Laboratory of Pattern Recognition,Institute of Automation,School of Future Technology,University of CAS,and CAS Center for Excellence in Brain Science and Intelligence Technology,Chinese Academy of Sciences,Shanghai,China;Theme Aging,Karolinska University Hospital,Huddinge,Sweden
Generic amyloid fibrillation of TMEM106B in patient with Parkinson's disease dementia and normal elders
Yun Fan;Qinyue Zhao;Wencheng Xia;Youqi Tao;Wenbo Yu;Mingjia Chen;Yiqi Liu;Jue Zhao;Yan Shen;Yunpeng Sun;Chenfang Si;Shenqing Zhang;Yaoyang Zhang;Wensheng Li;Cong Liu;Jian Wang;Dan Li-Department of Neurology and National Research Center for Aging and Medicine&National Center for Neurological Disorders,State Key Laboratory of Medical Neurobiology,Huashan Hospital,Fudan University,Shanghai,China;Bio-X Institutes,Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders(Ministry of Education),Shanghai Jiao Tong University,Shanghai,China;Bio-X-Renji Hospital Research Center,Renji Hospital,School of Medicine,Shanghai Jiao Tong University,Shanghai,China;Interdisciplinary Research Center on Biology and Chemistry,Shanghai Institute of Organic Chemistry,Chinese Academy of Sciences,Shanghai,China;University of Chinese Academy of Sciences,Beijing,China;Department of Anatomy and Histoembryology,School of Basic Medical Sciences,State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science,Institutes of Brain Science,Fudan University,Shanghai,China;Zhangjiang Institute for Advanced Study, Shanghai Jiao Tong University, Shanghai, China
Structural basis of the activation of metabotropic glutamate receptor 3
Wei Fang;Fan Yang;Chanjuan Xu;Shenglong Ling;Li Lin;Yingxin Zhou;Wenjing Sun;Xiaomei Wang;Peng Liu;Philippe Rondard;Pan Shi;Jean-Philippe Pin;Changlin Tian;Jianfeng Liu-The First Affiliated Hospital of USTC,School of Life Sciences,Division of Life Sciences and Medicine,Joint Center for Biological Analytical Chemistry,Anhui Engineering Laboratory of Peptide Drug,Anhui Laboratory of Advanced Photonic Science and Technology,University of Science and Technology of China,Hefei,Anhui,China;Key Laboratory of Molecular Biophysics of MOE,International Research Center for Sensory Biology and Technology of MOST,College of Life Science and Technology,Huazhong University of Science and Technology(HUST),Wuhan,Hubei,China;Bioland Laboratory,Guangzhou Regenerative Medicine and Health Guangdong Laboratory,Guangzhou,Guangdong,China;Institut de Génomique Fonctionnelle(IGF),Université de Montpellier,CNRS,INSERM,Montpellier,France
Corynoxine B derivative CB6 prevents Parkinsonian toxicity in mice by inducing PIK3C3 complex-dependent autophagy
Zhou Zhu;Liang-feng Liu;Cheng-fu Su;Jia Liu;Benjamin Chun-Kit Tong;Ashok lyaswamy;Senthilkumar Krishnamoorthi;Sravan Gopalkrishnashetty Sreenivasmurthy;Xin-jie Guan;Yu-xuan Kan;Wen-jian Xie;Chen-liang Zhao;King-ho Cheung;Jia-hong Lu;Jie-qiong Tan;Hong-jie Zhang;Ju-xian Song;Min Li-Mr.&Mrs.Ko Chi-Ming Centre for Parkinson's Disease Research,School of Chinese Medicine,Hong Kong Baptist University,Hong Kong,SAR,China;School of Chinese Medicine,Hong Kong Baptist University,Hong Kong,SAR,China;institute for Research and Continuing Education,Hong Kong Baptist University,Shenzhen 518057,China;Limin Pharmaceutical Factory,Livzon Group Limited,Shaoguan 512028,China;State Key Laboratory of Quality Research in Chinese Medicine,Institute of Chinese Medical Sciences,University of Macau,Macau,SAR,China;Center for Medical Genetics and Hunan Key Laboratory of Animal Model for Human Diseases,School of Life Sciences,Central South University,Changsha 410078,China;Medical College of Acupuncture-Moxibustion and Rehabilitation,Guangzhou University of Chinese Medicine,Guangzhou 510006,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。